Asperitas is a platform synthetic biology company translating raw biodiversity datasets into programmable products. We study specialized adaptations in non-model organisms to design novel biological pathways.
Asperitas Inc. is a platform synthetic biology company that discovers novel biological intelligence from the world's biodiversity and converts it into programmable products. We operate a vertically integrated pipeline — from sourcing rare and non-model organisms through global field networks, to analyzing their genetic, protein, and metabolic data with our proprietary Biological Knowledge Graph and AI, and finally engineering validated synthetic biology products.
Where traditional biotech relies on a narrow set of model organisms, Asperitas explores the vast, untapped reservoir of specialized adaptations found in nature — bioluminescent pathways, neurotoxin biosynthesis, extremophile resilience — and translates these into scalable applications across therapeutics, agriculture, industrial materials, and living design.
Headquartered in Delaware, USA, and incorporated as a C-Corporation, Asperitas maintains sourcing operations across 31+ countries and adheres strictly to international biodiversity conservation protocols including CITES and the Nagoya Protocol (ABS).
Countries with active sourcing operations
Rare species in our biodiversity portfolio
Specimens distributed globally since 2019
Founder & CEO
Read Bio →CTO
Read Bio →COO & AI Lead
Read Bio →CFO
Read Bio →Faculty
Read Bio →Faculty
Read Bio →Explore the latest Asperitas news from our team of experts.